Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Ramos-Dias

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Clinical Endocrinology|December 3, 1999
Iopanoic acid-induced decrease of circulating T3 causes a significant increase in GH responsiveness to GH releasing hormone in thyrotoxic patientsJ C Ramos-Dias, A M Lengyel
The Journal of Clinical Endocrinology and Metabolism|April 1, 1996
Different growth hormone (GH) response to GH-releasing peptide and GH-releasing hormone in hyperthyroidismJ C Ramos-Dias, F Pimentel-Filho, A F Reis, et al.
Journal of Endocrinological Investigation|December 13, 2003
Acute decrease in circulating T3 levels enhances, but does not normalise, the GH response to GHRP-6 plus GHRH in thyrotoxicosisS O Nascif, M H Senger, J C Ramos-Dias, et al.
Metabolism: Clinical and Experimental|June 1, 1997
Growth hormone (GH) response to GH-releasing peptide-6 in patients with insulin-dependent diabetes mellitusR F Villas-Boas Weffort, J C Ramos-Dias, C Chipoch, et al.
Clinical Endocrinology|November 1, 1995
Low circulating IGF-I levels in hyperthyroidism are associated with decreased GH response to GH-releasing hormoneJ C Ramos-Dias, M Yateman, C Camacho-Hübner, et al.
Clinical Endocrinology|March 1, 1997
Growth hormone responses to GH-releasing peptide (GHRP-6) in hypothyroidismF R Pimentel-Filho, J C Ramos-Dias, F B Ninno, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinical Endocrinology|December 3, 1999
Iopanoic acid-induced decrease of circulating T3 causes a significant increase in GH responsiveness to GH releasing hormone in thyrotoxic patientsJ C Ramos-Dias, A M Lengyel
The Journal of Clinical Endocrinology and Metabolism|April 1, 1996
Different growth hormone (GH) response to GH-releasing peptide and GH-releasing hormone in hyperthyroidismJ C Ramos-Dias, F Pimentel-Filho, A F Reis, et al.
Journal of Endocrinological Investigation|December 13, 2003
Acute decrease in circulating T3 levels enhances, but does not normalise, the GH response to GHRP-6 plus GHRH in thyrotoxicosisS O Nascif, M H Senger, J C Ramos-Dias, et al.
Metabolism: Clinical and Experimental|June 1, 1997
Growth hormone (GH) response to GH-releasing peptide-6 in patients with insulin-dependent diabetes mellitusR F Villas-Boas Weffort, J C Ramos-Dias, C Chipoch, et al.
Clinical Endocrinology|November 1, 1995
Low circulating IGF-I levels in hyperthyroidism are associated with decreased GH response to GH-releasing hormoneJ C Ramos-Dias, M Yateman, C Camacho-Hübner, et al.
Clinical Endocrinology|March 1, 1997
Growth hormone responses to GH-releasing peptide (GHRP-6) in hypothyroidismF R Pimentel-Filho, J C Ramos-Dias, F B Ninno, et al.
Pageof 1